Implantable oxygen-eating batteries help kill cancer
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
Neuroscientists at The University of Texas at Austin have discovered a group of cells in the brain that are responsible when a frightening memory re-emerges unexpectedly, like Michael Myers in every "Halloween" movie. The ...
Apr 1, 2019
2
771
A team of researchers from several institutions in Japan has found that a certain drug in conjunction with physical therapy has resulted in improved recovery from a stroke in mice and monkeys. In their paper published in ...
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...
Jan 9, 2018
0
892
(Medical Xpress)—It's a good news/bad news scenario: Researchers have made a new discovery about HIV that will redirect curative strategies toward latent reservoirs of HIV—that's the good news. The bad news is that they ...
(Medical Xpress)—Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of Medicine in St. ...
Mar 8, 2013
3
0
A Ludwig Cancer Research study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by interventions such as radiotherapy, ...
Sep 9, 2024
0
56
Researchers at Weill Cornell Medicine have used artificial intelligence to identify drug targets based on mapping regulatory networks in patient tumors. The study, published in Cell Systems, experimentally identified and ...
Sep 5, 2024
0
32
St. Jude Children's Research Hospital scientists report the first successful treatment of a pediatric patient with high-risk refractory neuroblastoma using a targeted therapy guided by clinical genomics.
Aug 15, 2024
0
22
People with Parkinson's disease are receiving a new treatment in a clinical trial started after University of Wisconsin–Madison scientists demonstrated the safety and feasibility of the therapeutic delivery method in a ...
Jul 29, 2024
0
63